Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients

Table 2

Treatment therapies at baseline.

	Number of subjects	Proportion (%)	Cumulative proportion (%)
Metformin	203	10.67	10.67
Xiaoke Pill	233	12.24	22.91
Other TCMs	137	7.20	30.11
Gliclazide	128	6.73	36.84
Acarbose	110	5.78	42.62
Xiaoke Pill+	177	9.30	51.92
Glibenclamide	12	0.63	52.55
Others	903	47.45	100.00
Total	1903	100.00

Note: we only kept those who have completed the baseline and all four follow-up surveys as well as two medical checks. Therapies in the category “others” are detailed in Appendix. TCMs refer to TCMs other than the Xiaoke Pill.